Navigation Links
CIGNA HealthCare and VITAS Innovative Hospice Care Enter Into a National Agreement
Date:6/23/2008

MIAMI, June 23 /PRNewswire/ -- VITAS Innovative Hospice Care(R) and CIGNA HealthCare have signed a national agreement to ensure access to quality hospice services for CIGNA's 5.1 million members who reside in major metro markets in the 16 states served by VITAS.

"As a hospice pioneer and innovator, VITAS has always been a leader in expanding access to hospice services nationwide," noted Tim O'Toole, CEO of VITAS Innovative Hospice Care. "Partnering with CIGNA, one of America's leading and most respected health service organizations, will ensure that VITAS can continue to meet the ever-increasing demand for quality, compassionate, responsive end-of-life care from those who seek to maximize quality of life when they have a limited time left to live."

"How we care for people as they approach the end of their life is every bit as important as how we care for them throughout their lifetime," said David Ferriss, M.D., national medical officer for CIGNA HealthCare. "That's why it's so important to find a hospice partner like VITAS that can provide dignified and compassionate end-of-life care to people covered by a CIGNA health plan."

VITAS provides quality, compassionate end-of-life care for adult and pediatric patients with a wide range of life-limiting illnesses, including but not limited to cancer, heart disease, stroke, lung disease, liver disease, kidney disease, multiple sclerosis, ALS, Alzheimer's, Parkinson's and AIDS.

CIGNA members will receive the full range of hospice services through VITAS. The coverage includes all prescription drugs, over-the-counter medications, medical equipment and supplies required to treat the patient's life-limiting illness. All four levels of hospice care -- routine home care, Intensive Comfort Care(SM) (called Continuous Care by Medicare), General Inpatient Care and Respite Care -- are covered. VITAS also provides a full range of bereavement support, including grief and loss programs, support groups
'/>"/>

SOURCE VITAS Innovative Hospice Care
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. CIGNA Group Insurance Shows Consumers Theres More to Life Through a New Consumer Education Toolkit
2. CIGNA Employees Take to the Road to Promote Health and Wellness
3. Dr. Allen Woolf Appointed Chief Medical Officer For CIGNA Group Insurance
4. Ken Sperling to Lead CIGNA HealthCare Retiree Solutions Unit
5. J.D. Power and Associates Reports: CIGNA HealthCare Recognized for Call Center Customer Satisfaction Excellence For a Second Consecutive Year
6. CIGNA Group Insurance Celebrates Return to Work Success During National Rehabilitation Awareness Week
7. CIGNA HealthCare Continues Gains in Health Care Quality
8. CIGNA Behavioral Health Offers Members Online Provider Profiles
9. ICMA/CIGNA Survey: U.S. Cities and Counties Begin to Focus on Health Risks and Costs
10. CIGNA Capitulates to Patient Revolt
11. RNs Statement on Death of Nataline Sarkisyan: CIGNA Should Have Listened to her Doctors and Approved the Transplant a Week Ago
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 21, 2013 Patients of Dr. Michael Shenk ... lost teeth due to gum disease and would like permanent ... disease treatment with laser gum surgery. Gum disease ... highest success rate out of all tooth replacement options. ... relatively new procedure cleared by the Food and Drug Administration ...
(Date:5/21/2013)... May 21, 2013 Parker Waichman LLP, a ... injured by defective medical devices, is offering remarks on the ... the Estate of Fred E. Taylor v. Intuitive Surgical, 09-2-03136-5, ... May 21, 2013, Bloomberg report noted that the ... a “car dealership” in how it deployed its strategy to ...
(Date:5/21/2013)... BOSTON (May 21, 2013) Prostaglandin analogues (PGAs), drugs ... of treatment for people with glaucoma, but their use ... with blurred vision, dryness, changes in eye color and ... that these drugs also cause upper and lower eyelid ... The findings are described in PLOS ONE . ...
(Date:5/21/2013)... May 21, 2013 Parker Waichman LLP, ... of victims injured by defective medical devices, is addressing ... Joint Surgery on May 15, 2013. The study found ... identify complications that occur in patients with metal-on-metal hip ... ( http://www.jbjs.org/article.aspx?articleid=1684770 ) , “We’ve known ...
(Date:5/21/2013)... HealthSmart continues to grow through strategic acquisitions ... the hiring of new talent in several areas, including ... that Dawn Powell has joined the organization effective April ... Account Management in the Central Region and is based ... extensive client management, employee benefits, and product development experience, ...
Breaking Medicine News(10 mins):Health News:Shenk Dental Care Stimulates Bone Growth for Gum Disease Patients Seeking Dental Implants with Laser Gum Surgery in Atlanta, GA 2Health News:Da Vinci Robotic Surgery Lawsuit: Parker Waichman LLP Reacts to Plaintiff’s Attorney’s Closing Argument in Which He Describes Intuitive Surgical as a Car Dealership 2Health News:Da Vinci Robotic Surgery Lawsuit: Parker Waichman LLP Reacts to Plaintiff’s Attorney’s Closing Argument in Which He Describes Intuitive Surgical as a Car Dealership 3Health News:Glaucoma drug can cause droopy eyelids 2Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 2Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 3Health News:New Talent Joins the HealthSmart Account Management Team 2
... to also feature performances by The 88 and Kreesha ... Fund for UNICEF announced,that Joel Madden, UNICEF Ambassador, and ... ceremony on Saturday, November 22 at,the intersection of Rodeo ... Beverly Hills, "Light the Night" annual holiday,event where the ...
... Include GPS Mapping via Google Earth and,Compatibility with ... LAKE SUCCESS, N.Y., Nov. 10 Polar ... and fitness assessment technology,today introduced the RS800CX, the ... endurance athletes and the growing,multisport market., The ...
... play a vital role in,Menicon,s expansion in the ... Ltd. announced the appointment of Jonathan Jacobson as,General ... Jacobson joined Menicon after serving at Bausch & ... many different executive positions,including Director of Marketing, Director ...
... of Interactive Bedside System Provides Hospitals with,Improved ... BETHESDA, Md., Nov. 10 GetWellNetwork, ... (IPC) solutions, today,announced the release of the ... interactive tool to help empower, engage and ...
... Jr., Successfully Uses C-Port System to Bypass ... in Patient with Brain Injury -, REDWOOD CITY, Calif., ... publication of a case study in the September,issue of the ... Distal Anastomosis System to connect blood vessels,in the brain to ...
... Montreal Heart Institute Research,Centre Director Dr. Jean-Claude ... demonstrating that VIA-2291, an investigational drug being,developed ... leukotrienes, proposed mediators of vascular inflammation, in ... with no serious,adverse events attributed to the ...
Cached Medicine News:Health News:Joel Madden and Nicole Richie to Flip the Switch at the UNICEF and City of Beverly Hills 2008 Snowflake Lighting 2Health News:Polar Introduces the RS800CX Training Management System for Multisport Endurance Athletes 2Health News:Polar Introduces the RS800CX Training Management System for Multisport Endurance Athletes 3Health News:Polar Introduces the RS800CX Training Management System for Multisport Endurance Athletes 4Health News:Jonathan Jacobson Appointed General Manager, Global Business Strategies & Operations, Menicon Co., Ltd. 2Health News:GetWellNetwork Introduces PatientLife System 3.0 2Health News:GetWellNetwork Introduces PatientLife System 3.0 3Health News:GetWellNetwork Introduces PatientLife System 3.0 4Health News:Cardica Announces Publication of Case Report in the Journal of Neurosurgery Featuring Use of C-Port(R) System in Brain Arterial Bypass 2Health News:Cardica Announces Publication of Case Report in the Journal of Neurosurgery Featuring Use of C-Port(R) System in Brain Arterial Bypass 3Health News:The Results From a Clinical Trial Led by the Montreal Heart Institute Demonstrate That Drug Reduces Inflammation in Patients With Serious Cardiovascular Disease 2Health News:The Results From a Clinical Trial Led by the Montreal Heart Institute Demonstrate That Drug Reduces Inflammation in Patients With Serious Cardiovascular Disease 3
(Date:5/21/2013)... 21, 2013  BioRestorative Therapies, Inc. ("BRT" or the ... on developing stem cell based therapies for various personal ... its President and CEO, will be presenting at the ... be held on Thursday, May 30, 2013 at the ... in New York City.  Mr. Weinreb,s presentation will take ...
(Date:5/21/2013)... , May 21, 2013 Ceregene, ... secondary analysis of its double-blind, randomized, controlled Phase ... a gene therapy product designed to deliver the ... analysis identified a more robust response to CERE-120 ... to treatment relative to those diagnosed 10 years ...
(Date:5/21/2013)... MONROVIA, Calif. , May 21, 2013 ... leading developer, manufacturer and marketer of minimally invasive ophthalmic ... upcoming investor conferences to review the Company,s recent financial ... STAAR Surgical will present at the 38 ... Boston at the Westin Waterfront ...
Breaking Medicine Technology:BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 2BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 3Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 2Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 3Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 4Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 5STAAR Surgical To Present At Upcoming Investor Conferences 2
... COLLEGEVILLE, Pa., and TARRYTOWN, N.Y., May 22 ... ), and Progenics,Pharmaceuticals, Inc. (Nasdaq: PGNX ), ... with investigational oral and,intravenous formulations of RELISTOR(TM) (methylnaltrexone ... phase 2 trial, evaluated the effects of,an oral ...
... LAS VEGAS, May 22 CardioVascular,BioTherapeutics, Inc. (OTC Bulletin ... Christopher Moore to be the sponsor and general,partner of ... of,$1 million and up to $10 million of the ... am extremely impressed with CVBT,s wound healing drug, which ...
Cached Medicine Technology:Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations 2Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations 3Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations 4Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations 5Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations 6Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations 7Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial 2Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial 3
... Adjustable Post-Operative Pin Knee Brace (POP) for ... associated with ACL, PCL, MCL, and LCL ... extension in 7 increments. Can be locked ... increases compliance. Breakaway hinge bar converts long ...
... The Aircast Patellar Brace is a ... unique "horseshoe" shaped aircell stabilizes the patella ... maintain the position of the patella. During ... helping to reduce swelling and pain. A ...
... Pediatric Knee/Elbow Cryo/Cuff is specifically designed to treat ... the therapeutic benefits of controlled compression to minimize ... Due to the unique design of the cuff, ... knee and elbow of the patient. The Pediatric ...
... therapeutic benefits of controlled compression to minimize hemarthrosis ... cuff is anatomically designed to completely fit the ... available in three sizes for adults and is ... children 1 - 7 years of age. A ...
Medicine Products: